Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Eur Urol. 2015 Aug 17;68(5):899–905. doi: 10.1016/j.eururo.2015.07.074

Table 1.

Clinical characteristics of patients who did not recover urinary function or erectile function by 12 mo after radical prostatectomy

Characteristic Urinary dysfunction cohort (n = 800) Erectile dysfunction cohort (n = 1003)
Patient age, yr 62 (57–67) 61 (56–65)

Preoperative PSA, ng/ml 5.1 (3.7–7.1) 5.1 (3.7–6.9)

Body mass index, kg/m2 28.1 (25.6–31.5) 27.8 (25.5–30.7)

Comorbidities
 0 225 (28) 337 (34)
 1 252 (32) 361 (36)
 2 211 (26) 221 (22)
 ≥3 112 (14) 84 (8.4)

Surgical approach
 Open 273 (34) 432 (43)
 Laparoscopic 226 (28) 289 (29)
 Robot assisted 301 (38) 282 (28)

Nerve-sparing status
 None 96 (12) 78 (7.8)
 Unilateral 137 (17) 175 (17)
 Bilateral 537 (67) 742 (74)
 Unknown 30 (3.8) 8 (0.8)

Pathologic stage
 T2 471 (59) 610 (61)
 T3 or higher 285 (36) 339 (34)
 Unknown 44 (5.5) 54 (5.4)

Pathologic Gleason score
 ≤6 154 (19) 196 (20)
 7 586 (73) 750 (75)
 ≥8 52 (6.5) 52 (5.2)
 Unknown 8 (1.0) 5 (0.5)

Positive surgical margin (%) 120 (15) 131 (13)

Median UF or EF score at 12 mo 14.0 (11.0–15.0) 8.0 (5.0–14.0)

EF = erectile function; PSA = prostate-specific antigen, UF = urinary function.

All values are median (interquartile range) or frequency (proportion).

Median UF or EF score for those who did not recover function by 12 mo.